Royalty Pharma (RPRX) Cash & Equivalents (2019 - 2026)
Royalty Pharma (RPRX) reported Cash & Equivalents of $513.66 million for Q3 2026, down 45.3% from $938.94 million a year earlier and down 36.7% from the prior quarter.
Powered by 
Analysis
Royalty Pharma (RPRX) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Royalty Pharma posted Cash & Equivalents of $618.7 million, down 33.4% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -9.3% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $929.03 million in FY2024 (+94.8%), $477.01 million in FY2023 (-72.1%), $1.71 billion in FY2022 (+11.0%) and $1.54 billion in FY2021 (+52.8%).
- The Q3 2026 figure ranks as the lowest quarterly Cash & Equivalents since Q4 2023.
- Year over year, Cash & Equivalents gained in three of the last eight quarters, with an average decline of 4.7%.
- The high point for year-over-year Cash & Equivalents in five years was Q1 2022 (growth of 152.7%); the low point was Q4 2023 (a decline of 72.1%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $811.99 million (Q2 2026), $586.4 million (Q1 2026) and $618.7 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Royalty Pharma | 39.80 Bn | 40.13 Bn | - | 513.66 Mn |
| 2 | Rocket Companies | 38.90 Bn | 27.72 Bn | - | 2.70 Bn |
| 3 | Orix | 38.66 Bn | 9.30 Bn | 13.83 Bn | 7.17 Bn |
| 4 | Federal National Mortgage Association Fannie Mae | 26.46 Bn | -16,107.65 Bn | - | 10.92 Bn |
| 5 | Synchrony Financial | 22.47 Bn | -45.15 Bn | - | 15.90 Bn |
| 6 | Affirm Holdings | 22.07 Bn | 15.11 Bn | - | 2.07 Bn |
| 7 | Royal Gold | 21.71 Bn | 20.92 Bn | 402.46 Mn | 184.54 Mn |
| 8 | Ares Capital | 13.84 Bn | 11.59 Bn | - | 722.00 Mn |
| 9 | Annaly Capital Management | 13.83 Bn | 4.86 Bn | - | 2.18 Bn |
| 10 | Federal Home Loan Mortgage | 12.64 Bn | -328.33 Bn | - | 4.56 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 513.66 Mn |
| Jun 30, 2026 | 811.99 Mn |
| Mar 31, 2026 | 586.40 Mn |
| Dec 31, 2025 | 618.70 Mn |
| Sep 30, 2025 | 938.94 Mn |
| Jun 30, 2025 | 631.91 Mn |
| Mar 31, 2025 | 1.09 Bn |
| Dec 31, 2024 | 929.03 Mn |
| Sep 30, 2024 | 950.05 Mn |
| Jun 30, 2024 | 1.76 Bn |
| Mar 31, 2024 | 843.00 Mn |
| Dec 31, 2023 | 477.01 Mn |
| Sep 30, 2023 | 936.45 Mn |
| Jun 30, 2023 | 2.17 Bn |
| Mar 31, 2023 | 1.98 Bn |
| Dec 31, 2022 | 1.71 Bn |
| Sep 30, 2022 | 991.63 Mn |
| Jun 30, 2022 | 2.11 Bn |
| Mar 31, 2022 | 1.79 Bn |
| Dec 31, 2021 | 1.54 Bn |
API Access
Royalty Pharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "RPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();